Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Faculty of Bioscience and Technology for Food, Agriculture, and Environment, University of Teramo, Teramo, Italy.
Adv Nutr. 2020 Jul 1;11(4):815-833. doi: 10.1093/advances/nmaa006.
The prevalence of overweight, obesity, and their related complications is increasing worldwide. The purpose of this umbrella review was to summarize and critically evaluate the effects of different diets on anthropometric parameters and cardiometabolic risk factors. Medline, Embase, Scopus, Cochrane Database of Systematic Reviews, and Web of Science, from inception to April 2019, were used as data sources to select meta-analyses of randomized controlled trials that examined the effects of different diets on anthropometric parameters and cardiometabolic risk factors. Strength and validity of the evidence were assessed through a set of predefined criteria. Eighty articles reporting 495 unique meta-analyses were examined, covering a wide range of popular diets: low-carbohydrate (n = 21 articles), high-protein (n = 8), low-fat (n = 9), paleolithic (n = 2), low-glycemic-index/load (n = 12), intermittent energy restriction (n = 6), Mediterranean (n = 11), Nordic (n = 2), vegetarian (n = 9), Dietary Approaches to Stop Hypertension (DASH) (n = 6), and portfolio dietary pattern (n = 1). Great variability in terms of definition of the intervention and control diets was observed. The methodological quality of most articles (n = 65; 81%), evaluated using the "A MeaSurement Tool to Assess systematic Reviews-2" questionnaire, was low or critically low. The strength of evidence was generally weak. The most consistent evidence was reported for the Mediterranean diet, with suggestive evidence of an improvement in weight, BMI, total cholesterol, glucose, and blood pressure. Suggestive evidence of an improvement in weight and blood pressure was also reported for the DASH diet. Low-carbohydrate, high-protein, low-fat, and low-glycemic-index/load diets showed suggestive and/or weak evidence of a reduction in weight and BMI, but contrasting evidence for lipid, glycemic, and blood pressure parameters, suggesting potential risks of unfavorable effects. Evidence for paleolithic, intermittent energy restriction, Nordic, vegetarian, and portfolio dietary patterns was graded as weak. Among all the diets evaluated, the Mediterranean diet had the strongest and most consistent evidence of a beneficial effect on both anthropometric parameters and cardiometabolic risk factors. This review protocol was registered at www.crd.york.ac.uk/PROSPERO/ as CRD42019126103.
超重、肥胖及其相关并发症的患病率在全球范围内呈上升趋势。本综述的目的是总结和批判性评估不同饮食对人体测量参数和心血管代谢危险因素的影响。使用 Medline、Embase、Scopus、Cochrane 系统评价数据库和 Web of Science 作为数据源,从成立到 2019 年 4 月,选择了元分析随机对照试验,以检查不同饮食对人体测量参数和心血管代谢危险因素的影响。通过一套预先确定的标准评估证据的强度和有效性。共检查了 80 篇报告 495 项独特元分析的文章,涵盖了广泛的流行饮食:低碳水化合物(n=21)、高蛋白(n=8)、低脂肪(n=9)、旧石器(n=2)、低血糖指数/负荷(n=12)、间歇性能量限制(n=6)、地中海(n=11)、北欧(n=2)、素食(n=9)、停止高血压的饮食方法(DASH)(n=6)和投资组合饮食模式(n=1)。观察到干预和对照饮食的定义存在很大差异。使用 "A MeaSurement Tool to Assess systematic Reviews-2" 问卷评估,大多数文章(n=65;81%)的方法学质量较低或极低。证据的强度通常较弱。地中海饮食报告的证据最一致,表明体重、BMI、总胆固醇、葡萄糖和血压有所改善。DASH 饮食也报告了体重和血压改善的提示性证据。低碳水化合物、高蛋白、低脂肪和低血糖指数/负荷饮食显示出减轻体重和 BMI 的提示性和/或弱证据,但血脂、血糖和血压参数的证据相互矛盾,表明可能存在不利影响的风险。旧石器、间歇性能量限制、北欧、素食和投资组合饮食模式的证据被评为弱。在所评估的所有饮食中,地中海饮食对人体测量参数和心血管代谢危险因素具有最强和最一致的有益影响。本综述方案在 www.crd.york.ac.uk/PROSPERO/ 上以 CRD42019126103 进行了注册。